title: Ivermectin cream improves health-related quality of life in patients with rosacea: data from a randomized trial.
authors.affiliation: Service de Dermatologie et Dermatologie Pédiatrique, Hôpital Saint-André, Bordeaux, France.
authors.forename: A
authors.initials: A
authors.lastname: Taieb
authors.affiliation: Service de Dermatologie, Hôpital Archet 2, Nice, France.
authors.forename: T
authors.initials: T
authors.lastname: Passeron
authors.affiliation: Department of Dermatology and Allergy, Ludwig-Maximilian Universität, Munich, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Ruzicka
authors.affiliation: Department of Dermatology, University Hospital, Coventry, U.K.
authors.forename: J
authors.initials: J
authors.lastname: Berth-Jones
authors.affiliation: Galderma R&D, Sophia Antipolis, France.
authors.forename: J
authors.initials: J
authors.lastname: Jacovella
authors.affiliation: School of Pharmacy, Temple University, Philadelphia, PA, 19140, U.S.A.
authors.forename: M Y
authors.initials: MY
authors.lastname: Huang
authors.affiliation: School of Pharmacy, Temple University, Philadelphia, PA, 19140, U.S.A.
authors.forename: A
authors.initials: A
authors.lastname: Wertheimer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003879:Dermatologic Agents / Q000008:administration & dosage*; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage*; D008795:Metronidazole / Q000008:administration & dosage; D008875:Middle Aged; D009824:Ointments; D011788:Quality of Life; D012393:Rosacea / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D003879:Dermatologic Agents; D009824:Ointments; D008795:Metronidazole; D007559:Ivermectin